Carboxyamidotriazole Delivers Potent Anti-Angiogenic, Safe, and Durable Treatment For Neovascular Ocular Disease

Time: 3:30 pm
day: Day Two


  • Carboxyamidotriazole has an extensive human safety profile after systemic administration
  • Carboxyamidotriazole is a novel chemical entity for ocular disease
  • Carboxyamidotriazole can be durably administered and is effective in multiple pre-clinical models of ocular neovascular disease